CPHI 2026 Global Pharma Events: Where World's Pharmaceutical Industry Connects
The pharmaceutical industry continues to become more interconnected than ever before. In 2026, the CPHI Global Event Series will once again bring together manufacturers, innovators, suppliers, distributors, contract development organizations, biotech companies, and healthcare professionals from across the globe.
From South East Asia to Korea, Shenzhen, Milan, India, and the rapidly growing Middle East, CPHI 2026 offers unmatched opportunities to discover new markets, build strategic partnerships, source products, and accelerate international business growth.
For companies looking to expand globally, attending multiple CPHI exhibitions is no longer optional—it has become a strategic investment.
CPHI 2026 Global Event Calendar
🇹🇭 CPHI South East Asia
Date: 8–10 July 2026
Venue: Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand
Southeast Asia continues to be one of the fastest-growing pharmaceutical regions, driven by increasing healthcare investments, expanding manufacturing capabilities, and rising demand for affordable medicines.
Why attend:
Pharmaceutical Ingredients
Finished Formulations
Contract Manufacturing
Packaging & Drug Delivery
ASEAN Market Expansion
Regulatory Networking
Ideal for companies targeting Thailand, Vietnam, Indonesia, Malaysia, Philippines, and Singapore.
🇰🇷 CPHI Korea
Date: 25–27 August 2026
Venue: COEX, Seoul, South Korea
South Korea has established itself as a global powerhouse in biopharmaceuticals, biosimilars, cell therapy, and advanced pharmaceutical manufacturing.
Key opportunities include:
Biologics
Biosimilars
CDMO Partnerships
Biotechnology Collaborations
Injectable Manufacturing
High-value Pharmaceutical APIs
This event attracts major Asian pharmaceutical innovators alongside international investors and technology providers.
🇨🇳 CPHI & PMEC Shenzhen
Date: 16–18 September 2026
Venue: Shenzhen Convention & Exhibition Center (SZCEC), China
Located in China's Greater Bay Area, Shenzhen has become one of Asia's leading innovation hubs.
Focus areas include:
Pharmaceutical Manufacturing Equipment
Active Pharmaceutical Ingredients (APIs)
Fine Chemicals
Pharmaceutical Packaging
Automation
Smart Manufacturing Technologies
The exhibition serves as an important gateway to China's rapidly evolving pharmaceutical market and manufacturing ecosystem.
🇮🇹 CPHI Milan
Date: 6–8 October 2026
Venue: Fiera Milano, Italy
CPHI Milan is widely recognized as one of the world's largest pharmaceutical exhibitions.
Thousands of exhibitors and delegates from over 160 countries gather to explore:
APIs
Finished Dosage Formulations
Biopharmaceuticals
Contract Research
CDMO Services
Packaging Innovation
Digital Healthcare
AI in Pharma
Regulatory Compliance
Whether you're seeking European market entry or global strategic alliances, Milan remains one of the industry's most influential networking destinations.
🇮🇳 CPHI India
Date: 23–25 November 2026
Venue: IICC, Yashobhoomi, New Delhi
India remains one of the world's leading pharmaceutical manufacturing destinations, supplying affordable medicines to more than 200 countries.
CPHI India showcases:
Generic Medicines
Injectable Manufacturing
Oncology Products
Vaccines
APIs
Nutraceuticals
Contract Manufacturing
Export Services
Regulatory Solutions
For global buyers seeking reliable manufacturing partners, India continues to offer exceptional quality, competitive pricing, and strong regulatory expertise.
🇸🇦 CPHI Middle East
Date: 14–16 December 2026
Venue: Riyadh Exhibition & Convention Centre, Malham, Saudi Arabia
The Middle East has rapidly emerged as one of the world's most promising pharmaceutical investment regions.
Driven by healthcare reforms, localization initiatives, and Vision 2030 programs, countries across the Gulf are investing heavily in pharmaceutical manufacturing and healthcare infrastructure.
Key opportunities include:
Government Procurement
Local Manufacturing Partnerships
Licensing Opportunities
Hospital Supply Chains
Generic Medicines
Biotechnology
Medical Devices
Saudi Arabia, the UAE, Qatar, Kuwait, Oman, Bahrain, Iraq, and neighboring markets are expected to generate significant pharmaceutical business opportunities over the coming decade.
Why Attend Multiple CPHI Events?
Each CPHI exhibition serves a distinct regional market while providing access to the global pharmaceutical ecosystem.
Participating in multiple events enables companies to:
Expand international distribution networks
Meet qualified buyers and procurement teams
Identify contract manufacturing opportunities
Launch innovative pharmaceutical products
Source APIs and excipients
Explore regulatory pathways
Connect with CROs, CDMOs, and biotechnology partners
Build long-term strategic alliances
PharpleQ Lifesciences: Connecting Global Healthcare Markets
At PharpleQ Lifesciences Pvt. Ltd., we believe that meaningful partnerships are the foundation of global healthcare growth.
Our expertise spans:
Pharmaceutical Business Development
International Market Expansion
Contract Manufacturing (CDMO)
Contract Research (CRO)
Product Registration Support
Global Pharmaceutical Sourcing
Healthcare Consulting
Regulatory Assistance
Export & Import Facilitation
Whether you're looking to enter new markets, identify manufacturing partners, or establish long-term collaborations, PharpleQ is committed to connecting businesses with trusted opportunities worldwide.
Let's Meet at CPHI 2026
If your organization plans to attend CPHI South East Asia, CPHI Korea, CPHI Shenzhen, CPHI Milan, CPHI India, or CPHI Middle East, we would be delighted to connect.
Let's explore opportunities in:
Business Development
Licensing & Technology Transfer
CDMO & CRO Collaborations
API & Finished Formulation Supply
International Distribution
Strategic Partnerships
Together, we can shape the future of global healthcare.
About PharpleQ Lifesciences Pvt. Ltd.
Quick. Quality. Quorum.
PharpleQ Lifesciences Pvt. Ltd. is a global healthcare business partner specializing in pharmaceutical consulting, international business development, contract manufacturing, CRO/CDMO collaborations, regulatory support, and worldwide market expansion. We work with healthcare companies, biotechnology firms, manufacturers, and healthcare innovators to accelerate sustainable global growth.